Panel | Digital Therapeutics: Scaling Software-Based, Individualized Interventions

Saturday FEbruary 27th, 2:00 PM CT - 2:45 PM CT

Imagine a world where biology and technology collide to provide targeted, tech-enabled therapies for 130+ million Americans diagnosed with at least one chronic condition. This vision is becoming reality as changemakers build not only the products, but also the principles and processes that will guide growth in digital therapeutics (DTx). This panel will bring together perspectives from payers, providers, and innovators to explore the obstacles and opportunities surrounding DTx products.

Megan Coder, PharmD, MBA
Executive Director
Digital Therapeutics Alliance
Moderator and Panelist

Gary Bennett, PhD
Founding Director
Duke Global Digital Health Science Center
Vice Provost of Undergraduate Education
Duke University
Panelist

Julia Strandberg, MBA
Chief Commercial Officer
Pear Therapeutics
Panelist

Saurabha Bhatnagar, MD
Chief Medical Officer, Head of Digital and Technology
UnitedHealthcare
Panelist

Seth Feuerstein, MD, JD
Executive Director and Founder
Yale Center for Digital Health and Innovation
Founder
Cobalt Therapeutics
Founder
Oui Health
Panelist